Holen Sie sich die Stockscreener-App
1.65
14.51%
-0.28
Handel nachbörslich:
1.59
-0.06
-3.64%
Schlusskurs vom Vortag:
$1.93
Offen:
$1.79
24-Stunden-Volumen:
2.72M
Relative Volume:
0.56
Marktkapitalisierung:
$53.26M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.14M
KGV:
-3.0556
EPS:
-0.54
Netto-Cashflow:
$-3.99M
1W Leistung:
+17.86%
1M Leistung:
+30.95%
6M Leistung:
-37.74%
1J Leistung:
-67.00%
1-Tages-Spanne:
$1.60
$1.8172
1-Wochen-Bereich:
$1.37
$2.091
52-Wochen-Spanne:
$1.12
$7.0791
Telomir Pharmaceuticals Inc Stock (TELO) Company Profile
Firmenname
Telomir Pharmaceuticals Inc
Sektor
Branche
Telefon
786-396-6723
Adresse
100 SE 2ND ST, MIAMI
Vergleichen Sie TELO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TELO
Telomir Pharmaceuticals Inc
|
1.65 | 65.29M | 0 | -16.14M | -3.99M | -0.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-21 | Eingeleitet | Rodman & Renshaw | Buy |
Telomir Pharmaceuticals Inc Aktie (TELO) Neueste Nachrichten
What drives Telomir Pharmaceuticals Inc stock priceIndustrial Stocks Review & Free Transform Portfolio With Stocks - earlytimes.in
Why Telomir Pharmaceuticals Inc. is moving todayMarket Sentiment Report & Real-Time Buy Signal Notifications - newser.com
Tools to assess Telomir Pharmaceuticals Inc.’s risk profileMarket Sentiment Report & Verified Swing Trading Watchlist - newser.com
Why Telomir Pharmaceuticals Stock Is Rising 40% Premarket Today - Stocktwits
Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells - DelmarvaNow.com
Institutional scanner results for Telomir Pharmaceuticals Inc.2025 Fundamental Recap & Risk Controlled Stock Alerts - newser.com
How to monitor Telomir Pharmaceuticals Inc. with trend dashboardsJuly 2025 Trade Ideas & Daily Chart Pattern Signal Reports - newser.com
Telomir Pharmaceuticals Inc. (TELO) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Why Is Telomir Pharmaceuticals Stock Trading Higher Today?Telomir Pharmaceuticals (NASDAQ:TELO) - Benzinga
Telomir Pharmaceuticals Announces In Vitro Data Showing Telomir-1 Targets Additional Histone Demethylase Families, a Unique Profile in Cancer and Aging Not Seen in Other Therapies - The Florida Times-Union
Telomir stock soars after drug shows promise against aggressive breast cancer - Investing.com
Telomir Pharma’s Cutting-Edge Cancer Breakthrough - StocksToTrade
Telomir’s Investigational Therapy: A Game Changer? - timothysykes.com
Pre-Market Titans: TTRX, BJDX & UPC Set The Pace - RTTNews
Telomir-1 shows promise against triple-negative breast cancer By Investing.com - Investing.com South Africa
Selective killing of aggressive TNBC cells: Telomir's Telomir‑1 disrupts iron-driven energy and mitochondrial function - Stock Titan
Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - inkl
Telomir Pharmaceuticals Announces New Findings in a Prostate Cancer Model Demonstrating Telomir-1 Also Resets DNA Methylation of Tumor Suppressor Genes Implicated in Two of the Most Persistent Challenges in Oncology-Metastasis and Treatment Re - The Florida Times-Union
Weiss Ratings Reiterates “Sell (E+)” Rating for Telomir Pharmaceuticals (NASDAQ:TELO) - Defense World
Telomir Pharmaceuticals Telomir-1 selectively kills aggressive triple-negative breast cancer cells - MarketScreener
Telomir Pharmaceuticals Unveils Promising Cancer Treatment Discovery - TipRanks
Telomir shares surge after breakthrough tumor suppressor gene reactivation data - MSN
Telomir stock soars after tumor suppressor gene reactivation results - Investing.com
Stock Market Today: Dow Jones, Nasdaq 100, S&P 500 Futures Turn Green—Trilogy Metals, AMD, Applovin In Focus (UPDATED) - Benzinga
Morning Market Movers: SPRB, LXEO, BMEA, Seeing Big Swings - RTTNews
Telomir Says Investigational Therapy Reactivates Tumor Suppressor Genes in Preclinical Models - MarketScreener
Telomir-1 shows promise in reactivating tumor suppressor genes By Investing.com - Investing.com Nigeria
Telomir-1 shows promise in reactivating tumor suppressor genes - Investing.com
Telomir Telomir-1 Resets DNA Methylation of MASPIN, RASSF1A | TELO Stock News - Stock Titan
Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket - Benzinga
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) Sees Significant Decrease in Short Interest - Defense World
McCormick, Telomir Pharmaceuticals And 3 Stocks To Watch Heading Into Tuesday - Benzinga
TELO, PCSA, RVPH, NMTC, BRTX Jump In After-Hours Trading On Light News Flow And Select Updates - RTTNews
What's Behind The Sharp 39% After-Hours Rally In Telomir Pharmaceuticals? - Benzinga
Telomir Pharmaceuticals Announces Promising Preclinical Findings - TipRanks
How moving averages guide Telomir Pharmaceuticals Inc. tradingIndex Update & Reliable Intraday Trade Plans - newser.com
How Telomir Pharmaceuticals Inc. stock performs in high volatility marketsMarket Sentiment Review & Entry Point Confirmation Signals - newser.com
Can GSM Foils Limited Compete Against Disruptor Stocks in Its SectorValue Stock Picks & Big Profit Low Capital - earlytimes.in
Will Telomir Pharmaceuticals Inc. stock maintain momentum in 2025GDP Growth & Safe Capital Growth Plans - newser.com
Finanzdaten der Telomir Pharmaceuticals Inc-Aktie (TELO)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):